Company
Company

Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.

Always stay updated with the free CMN Newsletter.

Recombinetics

Main focus: Development of gene-edited animals for various applications

Diseases (gene editing): Organ failure

Genome editing tool: CRISPR, TALEN

Funding stage: Private

Location: Minneapolis, Minnesota, USA

Website: https://recombinetics.com/

Recombinetics is gene-editing company, mainly focused on genetically engineering animals for agricultural and biomedical applications. The company's biomedical operations mainly take place through its subsidiaries, Regenevida, Surrogen and Makana Therapeutics. Regenevida develops patient-derived organ cells for improved transplantation, while Surrogen has been established to genetically engineer pigs to create improved disease models. Makana Therapeutics aims to genetically engineer pigs with the aim to enable xenotransplantation, thereby accommondating the increasing demand for transplantable organs.

Tags

HashtagRecombinetics

Company: Recombinetics
close
Search CRISPR Medicine